Articles

Rising immunity from vaccines and prior exposure means we should have COVID-19 cornered by Memorial Day. That doesn’t mean the virus will be out of our lives. But its impact should be reduced to something approaching a normal flu season in terms of deaths and hospitalizations.

The U.S. has no public organization dedicated to producing and evaluating HTAs despite the potential of HTAs providing critical input about price and value, while also recognizing the contribution of innovation to advancing health and healthcare.

Schaeffer Center researchers examined how use of insulin changes as cost-sharing fluctuates over the course of the year for Medicare Part D beneficiaries.

The most ethically justified path forward for COVID-19 vaccine distribution is to focus on individuals 65 and older. This group accounts for 80% of COVID-19 deaths despite making up only 16% of the population.

Eliminating administrative expense has the benefit of lowering health care costs without affecting spending on patient care.

Policymakers should ask the millions of people who have already survived the coronavirus infection to step to the back of the line for vaccines, argue Neeraj Sood and colleagues in CalMatters.

Scientific evidence suggests that extending travel bans will not make Americans safer, and instead result in adverse consequences for millions of family members who have been separated for over 10 months.

Analysis of a survey that was conducted between April and November of 2020 shows a concerning trend: Individuals reported engaging in 16 evidence-based protective measures less frequently in November compared to April. Only mask wearing was up considerably.

According to a survey of Americans conducted in December, only 63% of individuals surveyed said they would take the COVID-19 vaccine, down from 83% in March. Schaeffer Center hosted an expert webinar on strategies to increase vaccine adoption.

Local, independent pharmacies are being overlooked, and that’s a mistake.